StemCo Biomedical

About:

StemCo Biomedical is a developer of medical device products for stem cell transplantation

Website: http://www.stemcobiomedical.com/

Top Investors: Becton Dickinson India, Intersouth Partners, Tall Oaks Capital Partners, The Aurora Funds, The Trelys Funds

Description:

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

Total Funding Amount:

$13.8M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

1999-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2003-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai